Clinical Research Directory
Browse clinical research sites, groups, and studies.
Impact of a Multidisciplinary Assessment in Day Hospitalization Versus Standard Care on the Deployment of Supportive Oncology Care Recommended by the Personalized Post-cancer Plan in Patients at the End of Initial Treatment for Gynecological Ovarian and Endometrial Cancer Endometrial Cancer
Sponsor: Centre Francois Baclesse
Summary
This project proposes a structuring of supportive oncology care for the recovery phase after gynecological cancer (ovarian/trope/peritoneum or endometrium). Patients will be divided into three groups based on the identification of oncological support care needs. Patients with supportive oncology care needs will be randomized into two groups: the experimental group, receiving a personalized post-cancer plan with a multidisciplinary assessment of supportive oncology care needs in a day hospital and coordinated follow-up by the referring study nurse, and the control group, receiving a personalized post-cancer plan without a day hospital. Randomization will be stratified according to tumor location (ovary vs. endometrium), use of supportive oncology care during treatment, and treatment center. Patients with no need for supportive oncology care will be followed in an observational cohort. The main objective is to identify and manage the supportive oncology care needs of patients in remission from endometrial or ovarian cancer to improve their quality of life and post-treatment follow-up. A medico-economic analysis will be performed.
Key Details
Gender
FEMALE
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
268
Start Date
2024-06-07
Completion Date
2028-06-07
Last Updated
2026-01-08
Healthy Volunteers
No
Conditions
Interventions
Multidisciplinary assessment
Delivery of a personalized post-cancer plan with multidisciplinary assessment of oncology support care needs in a day hospital
Standard assesment
Delivery of a personalized post-cancer plan without a day hospital
Observational cohort
Patients with no cancer sequelae, no adverse effects and no need for oncological support care will not be randomized, but will be followed as part of an observational cohort
Locations (13)
CHU, Besançon
Besançon, France
François Baclesse
Caen, France
Centre Jean Perrin
Clermont-Ferrand, France
Centre Léon Bérard
Lyon, France
Hopital Diaconesses Croix Saint-Simon
Paris, France
Hopital Europeen George Pompidou
Paris, France
Hôpital COCHIN
Paris, France
Institut Curie
Paris, France
Hopital privé des Côtes d'Armor
Plérin, France
Institut Curie, St Cloud
Saint-Cloud, France
CHU, Saint Etienne
Saint-Etienne, France
CHU
Strasbourg, France
Gustave Roussy
Villejuif, France